drugset / Trial / NCT00536068

Platelet Inhibition by Aspirin, Acetaminophen and NSAID

NCT00536068

Completed 11 enrolled Kantonsspital Graubünden
RandomizedParallel-groupSingle-blindTreatment

Summary

Nonsteroidal antiinflammatory drugs such as diclofenac or naproxen may interfere with the inhibition of platelet aggregation by aspirin, because they all interact with the platelet cyclooxygenase.This may be of great clinical importance because of an increased cardiovascular event rate (myocardial infarction, stroke). The present randomized, controlled study analyses in vitro platelet aggregation under a combined treatment of healthy volunteers with aspirin and either acetaminophen, diclofenac, naproxen, or placebo.

Timeline

Start
2006-08
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1 g Oral
Subject Aspirin Small molecule 100 mg Oral
Subject Diclofenac Other / unclassified 50 mg Oral
Subject Naproxen Small molecule 250 mg Oral